Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Treatment Patterns and Outcomes Study in Patients With Unresectable Stage III and Metastatic (Stage IV) Melanoma in the United States

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03199846
Recruitment Status : Completed
First Posted : June 27, 2017
Last Update Posted : February 6, 2018
Information provided by (Responsible Party):
Bristol-Myers Squibb

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 30, 2017
Actual Study Completion Date : December 31, 2017